Summary
Emcure Pharma is acquiring the remaining 12.05% stake in Gennova Biopharmaceuticals, taking full control to simplify ownership and sharpen strategic focus. Samit Mehta will now lead Gennova, which plans to continue leveraging its biomanufacturing platforms, while former CEO Sanjay Singh has divested its mRNA business.